PRVA Privia Health Group, Inc.companySEC Filings & Insider Trading Activity 2026
Latest Privia Health Group, Inc. (PRVA) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 27, 2026, a 10-Q quarterly report filed on November 6, 2025, an 8-K current report filed on February 26, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Privia Health Group, Inc. (PRVA) (SEC CIK 1759655), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
AI 10-K Annual Report AnalysisLatest 10-K (2025-12-31)
Business Overview
- • Core business: technology-driven physician enablement platform combining regional medical group partnership with provider autonomy, focused on value-based care (VBC) and provider workflow optimization
- • New emphasis: expansion of Privia Women’s Health and Pediatrics platforms and growth in virtual health services (4.7M virtual visits by 1.5M patients in 2025)
Risk Factors
- • Cybersecurity incident risk with potential to compromise patient and business data, cause operational disruption, and trigger costly remediation and liability
- • Board-level oversight of cybersecurity risks involving CISO with 15+ years health IT leadership, ensuring monthly updates to executive leadership
Management Discussion & Analysis
- • Operating lease expense $3.2M in 2025 vs $2.8M in 2024 and $2.7M in 2023
- • Administrative service rebates $3.5M in 2025, $1.8M in 2024, $2.7M in 2023
AI 8-K Current Report AnalysisRecent 8-K Filings
Item 2.02: Results of Operations and Financial Condition
- • Q4 2025 earnings release issued Feb 26, 2026, covering quarter ended December 31, 2025
- • Full financial results contained in Exhibit 99.1 — press release is the primary source for revenue, earnings, and guidance figures
Annual Reports Archive10-K
AI-powered analysis of Privia Health Group, Inc. (PRVA) 10-K annual reports filed with SEC EDGAR.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of Privia Health Group, Inc. (PRVA) 8-K current reports disclosing material events.
Financial SummaryXBRL
| FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|
| Profitability | ||||
| Revenue | $1.4B | $1.7B | $1.7B | $2.1B |
| Operating Income | -$19.1M | $20.6M | $17.0M | $34.2M |
| Net Income | -$8.6M | $23.1M | $14.4M | $22.9M |
| Op. Margin | -1.4% | 1.2% | 1.0% | 1.6% |
| Net Margin | -0.6% | 1.4% | 0.8% | 1.1% |
| Balance Sheet | ||||
| Total Assets | $792.8M | $999.9M | $1.1B | $1.4B |
| Equity | $499.1M | $561.4M | $635.2M | $737.2M |
| ROE | -1.7% | 4.1% | 2.3% | 3.1% |
Source: XBRL financial data from Privia Health Group, Inc. (PRVA) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.
Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
10-K | Feb 27, 2026 | Dec 31, 2025 | Analysis | |
8-K | Feb 26, 2026 | — | Analysis | — |
8-K | Dec 8, 2025 | — | — | |
10-Q | Nov 6, 2025 | Sep 30, 2025 | — | |
10-Q | Aug 7, 2025 | Jun 30, 2025 | — | |
10-Q | May 8, 2025 | Mar 31, 2025 | — | |
10-K | Feb 27, 2025 | Dec 31, 2024 | — | |
10-Q | Nov 7, 2024 | Sep 30, 2024 | — | |
10-Q | Aug 8, 2024 | Jun 30, 2024 | — | |
10-Q | May 9, 2024 | Mar 31, 2024 | — | |
10-K | Feb 27, 2024 | Dec 31, 2023 | — | |
10-Q | Nov 3, 2023 | Sep 30, 2023 | — | |
10-Q | Aug 3, 2023 | Jun 30, 2023 | — | |
10-Q | May 4, 2023 | Mar 31, 2023 | — | |
10-K | Mar 1, 2023 | Dec 31, 2022 | — | |
10-Q | Nov 10, 2022 | Sep 30, 2022 | — | |
10-Q | Aug 11, 2022 | Jun 30, 2022 | — | |
10-Q | May 12, 2022 | Mar 31, 2022 | — | |
10-K | Mar 25, 2022 | Dec 31, 2021 | — | |
10-Q | Nov 8, 2021 | Sep 30, 2021 | — | |
10-Q | Aug 9, 2021 | Jun 30, 2021 | — | |
10-Q | May 28, 2021 | Mar 31, 2021 | — |
Frequently Asked Questions
What are the latest PRVA SEC filings in 2026?
Privia Health Group, Inc. (PRVA) has filed a 10-K annual report on February 27, 2026, a 10-Q quarterly report on November 6, 2025, an 8-K current report on February 26, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did PRVA file its most recent 10-K annual report?
Privia Health Group, Inc. (PRVA) filed its most recent 10-K annual report on February 27, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view PRVA 10-Q quarterly reports?
Privia Health Group, Inc. (PRVA)'s most recent 10-Q quarterly report was filed on November 6, 2025. SignalX displays every PRVA 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has PRVA filed recently?
Privia Health Group, Inc. (PRVA)'s most recent 8-K was filed on February 26, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find PRVA insider trading activity (Form 4)?
SignalX aggregates every PRVA Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does PRVA file with the SEC?
Privia Health Group, Inc. (PRVA) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new PRVA filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Privia Health Group, Inc. (PRVA).
What is PRVA's SEC CIK number?
Privia Health Group, Inc. (PRVA)'s SEC CIK (Central Index Key) number is 1759655. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1759655 to look up all PRVA filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Where can I find PRVA return on equity (ROE) and financial data?
SignalX extracts XBRL financial data from Privia Health Group, Inc. (PRVA) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.
Stay on top of Privia Health Group, Inc. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 22+ filings.